• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢呋辛和头孢他啶在人肺组织中的穿透性。

Penetration of cefuroxime and ceftazidime into human lungs.

作者信息

Perea E J, Ayarra J, García Iglesias M C, García Luque I, Loscertales J

机构信息

Department of Microbiology, University Hospital, Seville, Spain.

出版信息

Chemotherapy. 1988;34(1):1-7. doi: 10.1159/000238539.

DOI:10.1159/000238539
PMID:3280266
Abstract

We have studied the penetration of cefuroxime and ceftazidime into lung tissue of 40 patients subjected to pulmonary surgery. Samples of blood and lung tissue were taken 1 and 2 h after antibiotic administration. Patients were randomly assigned to four dosage schedule groups: group A received a single intravenous injection of 750 mg cefuroxime; the lung tissue levels at 1 and 2 h were 9.6 +/- 3.1 and 4.54 +/- 2.64 micrograms/g of cefuroxime; the percentage penetration from serum into the lung tissue was 33.7 and 34.6%, respectively. Group B patients received three doses of 750 mg cefuroxime; lung tissue levels were 17.1 +/- 7.7 and 14.7 +/- 5.4 micrograms/g, the percentage of penetration being 89.1 and 102.8% at 1 and 2 h. Group C received a single intravenous injection of 1 g ceftazidime; the lung tissue levels were 16.3 +/- 10.1 and 10 +/- 5.04 micrograms/g; the percentage of penetration from serum was 38.3 and 35.3%. Group D received three doses of 1 g ceftazidime; the lung tissue concentrations were 11.98 +/- 7.5 and 8.5 +/- 7.3 micrograms/g and the percentage of penetration 35.1 and 32.2% at 1 and 2 h after last dose.

摘要

我们研究了头孢呋辛和头孢他啶在40例接受肺部手术患者肺组织中的渗透情况。在给予抗生素后1小时和2小时采集血液和肺组织样本。患者被随机分为四个剂量方案组:A组接受单次静脉注射750mg头孢呋辛;1小时和2小时时肺组织中的水平分别为9.6±3.1和4.54±2.64μg/g头孢呋辛;从血清渗透到肺组织中的百分比分别为33.7%和34.6%。B组患者接受三剂750mg头孢呋辛;肺组织水平为17.1±7.7和14.7±5.4μg/g,1小时和2小时时的渗透百分比分别为89.1%和102.8%。C组接受单次静脉注射1g头孢他啶;肺组织水平为16.3±10.1和10±5.04μg/g;血清渗透百分比为38.3%和35.3%。D组接受三剂1g头孢他啶;末次给药后1小时和2小时时肺组织浓度分别为11.98±7.5和8.5±7.3μg/g,渗透百分比为35.1%和32.2%。

相似文献

1
Penetration of cefuroxime and ceftazidime into human lungs.头孢呋辛和头孢他啶在人肺组织中的穿透性。
Chemotherapy. 1988;34(1):1-7. doi: 10.1159/000238539.
2
Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion.通过持续静脉输注评估头孢唑林和头孢呋辛的组织穿透性。
Antimicrob Agents Chemother. 1990 Jun;34(6):1128-31. doi: 10.1128/AAC.34.6.1128.
3
Penetration of oral cefuroxime axetil into the human aqueous humor.口服头孢呋辛酯在人房水中的穿透性。
Ophthalmologica. 1997;211(4):229-31. doi: 10.1159/000310796.
4
[Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].
Pathol Biol (Paris). 1992 May;40(5):545-50.
5
[Concentrations of cefuroxime in the skin].[皮肤中头孢呋辛的浓度]
Jpn J Antibiot. 1988 Jan;41(1):10-7.
6
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.阿奇霉素、克拉霉素、环丙沙星和头孢呋辛在志愿者体内的单剂量肺内药代动力学
Antimicrob Agents Chemother. 1996 Jul;40(7):1617-22. doi: 10.1128/AAC.40.7.1617.
7
Penetration of prophylactic antibiotics into peritoneal fluid.预防性抗生素在腹膜液中的渗透。
Am J Surg. 1989 Jun;157(6):585-7. doi: 10.1016/0002-9610(89)90707-1.
8
Pulmonary penetration of ceftazidime.头孢他啶的肺穿透性。
J Chemother. 1995 Feb;7(1):50-4. doi: 10.1179/joc.1995.7.1.50.
9
Antibiotic concentrations in the groin wound after vascular prosthetic implantation.
Pharm Weekbl Sci. 1991 Aug 23;13(4):179-81. doi: 10.1007/BF01957743.
10
[Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
Hinyokika Kiyo. 1991 Jun;37(6):659-62.

引用本文的文献

1
Anti-inflammatory effects of antibacterials on human Bronchial epithelial cells.抗菌药物对人支气管上皮细胞的抗炎作用。
Respir Res. 2009 Sep 29;10(1):89. doi: 10.1186/1465-9921-10-89.
2
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.头孢他啶。其抗菌活性、药代动力学特性及治疗效果的最新进展。
Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008.
3
Clinical pharmacokinetics of newer cephalosporins.新型头孢菌素的临床药代动力学
Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003.
4
Pharmacokinetics and tissue concentrations of cefuroxime.头孢呋辛的药代动力学和组织浓度
Pharm Weekbl Sci. 1990 Dec 14;12(6A):262-6; discussion 267. doi: 10.1007/BF01967830.